Down 26%, Is IBM Stock the Smartest Dividend Stock to Buy for the Second Half of 2026?

IBM’s issue is less about one weak quarter and more about budget displacement: when enterprise capex gets rerouted into infrastructure components, IBM’s mix is exposed because its sales engine depends on closing large, timing-sensitive deals. That creates a nasty near-term loop — delayed closes hit revenue, which can then pressure the credibility of the full-year target even if the underlying demand story is intact. The key question for the next 1-2 quarters is whether this is a pure timing problem or evidence that IBM is losing specification battles inside the CIO wallet.

The second-order beneficiary is not IBM’s direct software peers so much as the storage/silicon stack: Micron (MU) benefits today because constrained supply supports pricing power and forces customers to pre-buy, while downstream OEMs and infrastructure vendors can see temporary pull-forward demand. But if that tightness persists into 2H, it can also crowd out discretionary spend elsewhere in enterprise tech, which is a headwind for other large-cap IT vendors with slower product cycles. The z17 narrative only matters if it converts into measurable bookings and backlog; otherwise it remains a call option on future AI inference workloads rather than a near-term earnings driver.

The contrarian view is that the selloff may already discount an execution miss that is more transitory than structural, especially given IBM’s cash return profile. Still, the market usually re-rates IBM on confidence in guidance delivery, not on product promises, so the real catalyst is the July print: if management trims revenue or FCF, the multiple can compress further despite the dividend. If guidance holds, the setup shifts from value-trap risk to mean reversion; if it doesn’t, support from yield buyers is unlikely to stop another leg lower.